Selected research
Industry Research
AI Pathology Software Industry Research Report 2026
Market perspective
The global AI Pathology Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI Pathology Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Pathology Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Pathology Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Pathology Software include Aiforia Technologies Plc, Ibex Medical Analytics Ltd., Proscia Inc., Philips, Roche Diagnostics International Ltd, Leica Biosystems Nussloch GmbH, Fujifilm Holdings Corporation, Visiopharm A/S and Tempus AI, Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI Pathology Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Pathology Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI Pathology Software Market by Company
Aiforia Technologies Plc
Ibex Medical Analytics Ltd.
Proscia Inc.
Philips
Roche Diagnostics International Ltd
Leica Biosystems Nussloch GmbH
Fujifilm Holdings Corporation
Visiopharm A/S
Tempus AI, Inc.
Yitu Technology Co., Ltd.
Deepwise Healthcare Technology Co., Ltd.
PathAI, Inc.
Paige AI, Inc.
Indica Labs
AI Pathology Software Segment by Type
Histopathology AI Analysis Software
Cytopathology AI Analysis Software
Immunohistochemistry AI Analysis Software
Molecular Pathology AI Analysis Software
AI Pathology Software Segment by Application
Hospital Pathology Department
Third-party Medical Testing Laboratory
Pharmaceutical R&D
AI Pathology Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Pathology Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Histopathology AI Analysis Software
- Cytopathology AI Analysis Software
- Immunohistochemistry AI Analysis Software
- Molecular Pathology AI Analysis Software
Applications
- Hospital Pathology Department
- Third-party Medical Testing Laboratory
- Pharmaceutical R&D
Companies covered
- Aiforia Technologies Plc
- Ibex Medical Analytics Ltd.
- Proscia Inc.
- Philips
- Roche Diagnostics International Ltd
- Leica Biosystems Nussloch GmbH
- Fujifilm Holdings Corporation
- Visiopharm A/S
- Tempus AI, Inc.
- Yitu Technology Co., Ltd.
- Deepwise Healthcare Technology Co., Ltd.
- PathAI, Inc.
- Paige AI, Inc.
- Indica Labs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI Pathology Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Histopathology AI Analysis Software
- 2.2.3 Cytopathology AI Analysis Software
- 2.2.4 Immunohistochemistry AI Analysis Software
- 2.2.5 Molecular Pathology AI Analysis Software
- 2.3 AI Pathology Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pathology Department
- 2.3.3 Third-party Medical Testing Laboratory
- 2.3.4 Pharmaceutical R&D
- 2.4 Assumptions and Limitations
3 AI Pathology Software Breakdown Data by Type
- 3.1 Global AI Pathology Software Historic Market Size by Type (2021-2026)
- 3.2 Global AI Pathology Software Forecasted Market Size by Type (2027-2032)
4 AI Pathology Software Breakdown Data by Application
- 4.1 Global AI Pathology Software Historic Market Size by Application (2021-2026)
- 4.2 Global AI Pathology Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI Pathology Software Market Perspective (2021-2032)
- 5.2 Global AI Pathology Software Growth Trends by Region
- 5.2.1 Global AI Pathology Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI Pathology Software Historic Market Size by Region (2021-2026)
- 5.2.3 AI Pathology Software Forecasted Market Size by Region (2027-2032)
- 5.3 AI Pathology Software Market Dynamics
- 5.3.1 AI Pathology Software Industry Trends
- 5.3.2 AI Pathology Software Market Drivers
- 5.3.3 AI Pathology Software Market Challenges
- 5.3.4 AI Pathology Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI Pathology Software Players by Revenue
- 6.1.1 Global Top AI Pathology Software Players by Revenue (2021-2026)
- 6.1.2 Global AI Pathology Software Revenue Market Share by Players (2021-2026)
- 6.2 Global AI Pathology Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI Pathology Software Head Office and Area Served
- 6.4 Global AI Pathology Software Players, Product Type & Application
- 6.5 Global AI Pathology Software Manufacturers Established Date
- 6.6 Global AI Pathology Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI Pathology Software Market Size (2021-2032)
- 7.2 North America AI Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI Pathology Software Market Size by Country (2021-2026)
- 7.4 North America AI Pathology Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI Pathology Software Market Size (2021-2032)
- 8.2 Europe AI Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI Pathology Software Market Size by Country (2021-2026)
- 8.4 Europe AI Pathology Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI Pathology Software Market Size (2021-2032)
- 9.2 Asia-Pacific AI Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI Pathology Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI Pathology Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI Pathology Software Market Size (2021-2032)
- 10.2 South America AI Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI Pathology Software Market Size by Country (2021-2026)
- 10.4 South America AI Pathology Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI Pathology Software Market Size (2021-2032)
- 11.2 Middle East & Africa AI Pathology Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI Pathology Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI Pathology Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aiforia Technologies Plc
- 12.1.1 Aiforia Technologies Plc Company Information
- 12.1.2 Aiforia Technologies Plc Business Overview
- 12.1.3 Aiforia Technologies Plc Revenue in AI Pathology Software Business (2021-2026)
- 12.1.4 Aiforia Technologies Plc AI Pathology Software Product Portfolio
- 12.1.5 Aiforia Technologies Plc Recent Developments
- 12.2 Ibex Medical Analytics Ltd.
- 12.2.1 Ibex Medical Analytics Ltd. Company Information
- 12.2.2 Ibex Medical Analytics Ltd. Business Overview
- 12.2.3 Ibex Medical Analytics Ltd. Revenue in AI Pathology Software Business (2021-2026)
- 12.2.4 Ibex Medical Analytics Ltd. AI Pathology Software Product Portfolio
- 12.2.5 Ibex Medical Analytics Ltd. Recent Developments
- 12.3 Proscia Inc.
- 12.3.1 Proscia Inc. Company Information
- 12.3.2 Proscia Inc. Business Overview
- 12.3.3 Proscia Inc. Revenue in AI Pathology Software Business (2021-2026)
- 12.3.4 Proscia Inc. AI Pathology Software Product Portfolio
- 12.3.5 Proscia Inc. Recent Developments
- 12.4 Philips
- 12.4.1 Philips Company Information
- 12.4.2 Philips Business Overview
- 12.4.3 Philips Revenue in AI Pathology Software Business (2021-2026)
- 12.4.4 Philips AI Pathology Software Product Portfolio
- 12.4.5 Philips Recent Developments
- 12.5 Roche Diagnostics International Ltd
- 12.5.1 Roche Diagnostics International Ltd Company Information
- 12.5.2 Roche Diagnostics International Ltd Business Overview
- 12.5.3 Roche Diagnostics International Ltd Revenue in AI Pathology Software Business (2021-2026)
- 12.5.4 Roche Diagnostics International Ltd AI Pathology Software Product Portfolio
- 12.5.5 Roche Diagnostics International Ltd Recent Developments
- 12.6 Leica Biosystems Nussloch GmbH
- 12.6.1 Leica Biosystems Nussloch GmbH Company Information
- 12.6.2 Leica Biosystems Nussloch GmbH Business Overview
- 12.6.3 Leica Biosystems Nussloch GmbH Revenue in AI Pathology Software Business (2021-2026)
- 12.6.4 Leica Biosystems Nussloch GmbH AI Pathology Software Product Portfolio
- 12.6.5 Leica Biosystems Nussloch GmbH Recent Developments
- 12.7 Fujifilm Holdings Corporation
- 12.7.1 Fujifilm Holdings Corporation Company Information
- 12.7.2 Fujifilm Holdings Corporation Business Overview
- 12.7.3 Fujifilm Holdings Corporation Revenue in AI Pathology Software Business (2021-2026)
- 12.7.4 Fujifilm Holdings Corporation AI Pathology Software Product Portfolio
- 12.7.5 Fujifilm Holdings Corporation Recent Developments
- 12.8 Visiopharm A/S
- 12.8.1 Visiopharm A/S Company Information
- 12.8.2 Visiopharm A/S Business Overview
- 12.8.3 Visiopharm A/S Revenue in AI Pathology Software Business (2021-2026)
- 12.8.4 Visiopharm A/S AI Pathology Software Product Portfolio
- 12.8.5 Visiopharm A/S Recent Developments
- 12.9 Tempus AI, Inc.
- 12.9.1 Tempus AI, Inc. Company Information
- 12.9.2 Tempus AI, Inc. Business Overview
- 12.9.3 Tempus AI, Inc. Revenue in AI Pathology Software Business (2021-2026)
- 12.9.4 Tempus AI, Inc. AI Pathology Software Product Portfolio
- 12.9.5 Tempus AI, Inc. Recent Developments
- 12.10 Yitu Technology Co., Ltd.
- 12.10.1 Yitu Technology Co., Ltd. Company Information
- 12.10.2 Yitu Technology Co., Ltd. Business Overview
- 12.10.3 Yitu Technology Co., Ltd. Revenue in AI Pathology Software Business (2021-2026)
- 12.10.4 Yitu Technology Co., Ltd. AI Pathology Software Product Portfolio
- 12.10.5 Yitu Technology Co., Ltd. Recent Developments
- 12.11 Deepwise Healthcare Technology Co., Ltd.
- 12.11.1 Deepwise Healthcare Technology Co., Ltd. Company Information
- 12.11.2 Deepwise Healthcare Technology Co., Ltd. Business Overview
- 12.11.3 Deepwise Healthcare Technology Co., Ltd. Revenue in AI Pathology Software Business (2021-2026)
- 12.11.4 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product Portfolio
- 12.11.5 Deepwise Healthcare Technology Co., Ltd. Recent Developments
- 12.12 PathAI, Inc.
- 12.12.1 PathAI, Inc. Company Information
- 12.12.2 PathAI, Inc. Business Overview
- 12.12.3 PathAI, Inc. Revenue in AI Pathology Software Business (2021-2026)
- 12.12.4 PathAI, Inc. AI Pathology Software Product Portfolio
- 12.12.5 PathAI, Inc. Recent Developments
- 12.13 Paige AI, Inc.
- 12.13.1 Paige AI, Inc. Company Information
- 12.13.2 Paige AI, Inc. Business Overview
- 12.13.3 Paige AI, Inc. Revenue in AI Pathology Software Business (2021-2026)
- 12.13.4 Paige AI, Inc. AI Pathology Software Product Portfolio
- 12.13.5 Paige AI, Inc. Recent Developments
- 12.14 Indica Labs
- 12.14.1 Indica Labs Company Information
- 12.14.2 Indica Labs Business Overview
- 12.14.3 Indica Labs Revenue in AI Pathology Software Business (2021-2026)
- 12.14.4 Indica Labs AI Pathology Software Product Portfolio
- 12.14.5 Indica Labs Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst